You are here

J&J kicks off final study of single-shot Covid-19 vaccine in 60,000 volunteers

yq-jnj-22092024.jpg
Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot Covid-19 vaccine that potentially would simplify distribution of millions of doses compared with leading rivals using two doses.

[CHICAGO] Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot Covid-19 vaccine that potentially would simplify distribution of millions of doses compared with leading rivals using two doses.

The company expects results of the Phase III trial by year...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes